StockWatch
·
Pharmaceuticals
Corporate Action10 Oct 2026, 07:20 pm

Accretion Nutraveda Amends Memorandum of Association

AI Summary

Accretion Nutraveda Ltd has successfully amended its Memorandum of Association (MOA) after shareholder approval via postal ballot. The alteration focuses on Clause III, specifically the Object Clause. Key changes include the insertion and/or substitution of the Main Object Clause III(A) and the addition of new sub-clauses under Clause III(B), numbered III(B)(58) to III(B)(69). This amendment broadens the company's stated business objectives, particularly within the nutraceuticals, pharmaceuticals, cosmetics, and healthcare equipment sectors, allowing for expanded operations and services.

Key Highlights

  • Shareholder approval obtained for MOA alteration via postal ballot.
  • Object Clause III of the Memorandum of Association has been amended.
  • New sub-clauses (III(B)(58) to III(B)(69)) have been added.
  • Expansion of business objectives in nutraceuticals and healthcare sectors.
  • Company can now pursue a wider range of related activities.